Skip to Content
Merck
  • A NOS3 polymorphism determines endothelial response to folate in children with type 1 diabetes or obesity.

A NOS3 polymorphism determines endothelial response to folate in children with type 1 diabetes or obesity.

The Journal of pediatrics (2014-12-06)
Esko J Wiltshire, Alexia S Peña, Karen MacKenzie, Tulika Bose-Sundernathan, Roger Gent, Jennifer J Couper
ABSTRACT

To determine the effect of polymorphisms in NOS3 and folate pathway enzymes on vascular function and folate status and endothelial response to folate in children with diabetes or obesity. A total of 244 subjects (age 13.8 ± 2.8 years, 125 males) were studied for NOS3 and/or folate pathway polymorphisms using polymerase chain reaction/restriction fragment length polymorphism, including at baseline: 139 with type 1 diabetes; 58 with obesity; and 47 controls. The effect of NOS3 genotype on endothelial response to folate (5 mg) was assessed in 85 subjects with diabetes and 28 obese subjects who received active treatment during intervention trials. Vascular function (flow-mediated dilatation [FMD] and glyceryl trinitrate-mediated dilatation), clinical, and biochemical measurements were assessed at baseline and 8 weeks in folate intervention studies. Folate pathway enzyme and NOS3 polymorphisms did not significantly affect baseline vascular function. The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ± 5% (insertion carriers) vs 2.3 ± 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ± 5.4% (insertion carriers) and deteriorated by -3.2 ± 7.2% (deletion carriers), P = .05. More subjects carrying the insertion normalized FMD after folate supplementation (insertion 64% vs deletion 28%, χ(2) = 10.14, P = .001). A NOS3 polymorphism predicts endothelial response to folate in children with diabetes or obesity, with implications for vascular risk and folate intervention studies.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Vitamin B12, Vetec, reagent grade, ≥98%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Vitamin B12, ≥98%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Vitamin B12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
SKU
Pack Size
Availability
Price
Quantity
Cyanocobalamin, British Pharmacopoeia (BP) Assay Standard
SKU
Pack Size
Availability
Price
Quantity
Cyanocobalamin, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Supelco
Cyanocobalamin (B12), analytical standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Cyanocobalamin, meets USP testing specifications
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Cyanocobalamin, tested according to Ph. Eur.
SKU
Pack Size
Availability
Price
Quantity
Supelco
Cyanocobalamin, pharmaceutical secondary standard, certified reference material
SKU
Pack Size
Availability
Price
Quantity